(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-KCDTWFW'); window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-QYWG9MRT4K'); { "@context" : "http://schema.org", "@type" : "Organization", "url" : "https://liminal.miara.co.uk", "name" : "Liminal BioSciences", "sameAs" : [ "https://twitter.com/LiminalBio", "https://www.linkedin.com/company/liminal-biosciences-inc", "https://www.youtube.com/channel/UCrz1TGGazdWvsF8HfDMTlyg" ] }
!function(e,t,n,s,u,a){e.twq||(s=e.twq=function(){s.exe?s.exe.apply(s,arguments):s.queue.push(arguments); },s.version='1.1',s.queue=[],u=t.createElement(n),u.async=!0,u.src='//static.ads-twitter.com/uwt.js', a=t.getElementsByTagName(n)[0],a.parentNode.insertBefore(u,a))}(window,document,'script'); // Insert Twitter Pixel ID and Standard Event data below twq('init','o00tv'); twq('track','PageView');

The Q1 2023 quarterly report can be accessed using the link below

Dedicated to the treatment of metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach

About us

Liminal BioSciences is a development-stage biopharmaceutical company focused on developing distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases using our drug discovery platform and data-driven approach.

Read More

Product pipeline

Our expertise in small molecules has enabled a strong pipeline with potential first/best-in-class drug candidates.

Read More